Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.

More information: Dongyin He et al, Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2422267122 ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with ...

Of the 167 patients, 36 had metastatic castration-sensitive prostate cancer (mCSPC), 48 received first-line treatment for castration-resistant prostate cancer (mCRPC) and 83 received 2 or more ...

When prostate cancer is more advanced and spreads, the bones are among the areas most likely to be affected. It can also commonly spread to the lymph nodes, liver or lungs, according to the Mayo ...